CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

OxyContin maker Purdue Pharma agrees to $6bn bankruptcy deal

By Ernie Sadashige

20:15, 3 March 2022

OxyContin bottles
The revised agreement adds an additional $1.175bn in guaranteed payments in additional contingent payments – Photo: Shutterstock

The contentious battle over a founding family’s responsibility for thousands of opioid addictions may conclude next week.

A US bankruptcy court judge in New York will consider on 9 March whether to approve a proposed $6bn (£4.5bn) bankruptcy settlement between OxyContin maker Purdue Pharma, its founding Sackler family, and eight states and the District of Columbia.

“We’re pleased with the settlement achieved in mediation, under which all of the additional settlement funds will be used for opioid abatement programmes, overdose rescue medicines, and victims,” Purdue said in an emailed statement to Capital.com.

National overdose deaths involving prescription opioidsNational overdose deaths involving prescription opioids – National Institute of Drug Abuse

Second try

A US district court judge in December tossed out a previously agreed $4.5bn settlement that provided millions of dollars to opioid abatement trusts while shielding Purdue’s founding Sackler family from civil liability from damages caused by addiction.

The revised agreement adds an additional $1.175bn in guaranteed payments and up to $500m in additional contingent payments, a court document said.

States including California, Maryland, and Washington were among those that contested the original plan because it would bar further legal actions against the Sacklers. They appealed the court order that would allow Purdue to exit bankruptcy with the settlement in hand.

The new agreement removes this protection. Instead, it lets the states decide whether to release the Sacklers from possible criminal wrongdoing, tweeted University of North Carolina law professor Melissa Jacoby. The bankruptcy law expert noted the deal is silent on the treatment of personal injury claims.

A question of apology

Connecticut Attorney General William Tong praised the agreement because it includes an apology and a provision allowing institutions to remove the Sackler name from buildings and scholarships.

“After years of lies and denial, the Sackler family must now directly apologise for the pain they have caused. They must reckon face-to-face with the survivors of their reckless greed at a public hearing,” Tong said.

Jacoby told Capital.com that she doesn’t read the settlement terms as an apology.

The agreement requires a spokesperson for the Sacklers to issue a statement that reads in part, “While the families have acted lawfully in all respects, they sincerely regret that OxyContin, a prescription medicine that continues to help people suffering from chronic pain, unexpectedly became part of an opioid crisis that has brought grief and loss to far too many families and communities.”

The term sheet said the statement was not an admission of any wrongdoing or liability.

ETH/USD

3,586.10 Price
+2.060% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

XRP/USD

0.63 Price
+1.510% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,196.25 Price
+0.070% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.50

US100

18,249.40 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

However, California attorney general Rob Bonta said the deal’s mediator is urging the bankruptcy court to require the Sacklers to participate in a public hearing where victims and their survivors would be given an opportunity to directly address the family.

The Sacklers will pay the settlement over 18 years, with larger payments frontloaded, allowing the states to receive more faster than in the original plan, Tong said.

Opioid trusts

Purdue’s bankruptcy plan would transfer substantially all company assets to a new entity with a public-minded mission. The new company, called Knoa Pharma, would develop and distribute millions of doses of opioid addiction treatment and overdose reversal medicines.

The new company will be owned mostly by the National Opioid Abatement Trust (NOAT) as well as a trust established to benefit Native American tribes. Proceeds will also flow to opioid abatement trusts established for the benefit of other creditors such as hospitals, schools and children.

“With this mediation result… we hope to swiftly deliver these resources,” Purdue said today.

The Sacklers have no role in the new company.

National Drug-Involved Overdose DeathsNational drug-involved overdose deaths - Credit: National Institute of Drug Abuse

Bankruptcy filing

Purdue Pharma and 23 affiliated debtors filed for Chapter 11 bankruptcy in September 2019 in the US Bankruptcy Court for the Southern District of New York.

The company filed for bankruptcy after reaching an agreement in principle on a framework for settling US opioid litigation with 24 state attorneys general, analogous officials from five US territories and others.

Purdue had been the target of more than 2,900 civil actions generally alleging the company falsely and deceptively marketed OxyContin and other opioid pain medications.

The settlement is conditioned upon approval by the bankruptcy court, on the Second Circuit’s reversal of the District Court’s order, and consummation of the bankruptcy plan.

Rate this article

Related reading

The difference between trading assets and CFDs
The main difference between CFD trading and trading assets, such as commodities and stocks, is that you don’t own the underlying asset when you trade on a CFD.
You can still benefit if the market moves in your favour, or make a loss if it moves against you. However, with traditional trading you enter a contract to exchange the legal ownership of the individual shares or the commodities for money, and you own this until you sell it again.
CFDs are leveraged products, which means that you only need to deposit a percentage of the full value of the CFD trade in order to open a position. But with traditional trading, you buy the assets for the full amount. In the UK, there is no stamp duty on CFD trading, but there is when you buy stocks, for example.
CFDs attract overnight costs to hold the trades (unless you use 1-1 leverage), which makes them more suited to short-term trading opportunities. Stocks and commodities are more normally bought and held for longer. You might also pay a broker commission or fees when buying and selling assets direct and you’d need somewhere to store them safely.
Capital Com is an execution-only service provider. The material provided in this article is for information purposes only and should not be understood as investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents and has not been prepared in accordance with the legal requirements designed to promote investment research independence. While the information in this communication, or on which this communication is based, has been obtained from sources that Capital.com believes to be reliable and accurate, it has not undergone independent verification. No representation or warranty, whether expressed or implied, is made as to the accuracy or completeness of any information obtained from third parties. If you rely on the information on this page, then you do so entirely at your own risk.

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading